The "Pro" designation matters
Similarly, the SUSTAIN-6 trial revealed that subcutaneous semaglutide reduced MACE by 26% in patients with type 2 diabetes at high risk for heart problems
Potential risks include: Low blood sugar, especially if you also take other diabetes medications Gallbladder issues Mild to severe allergic reactions, including anaphylaxis in rare cases Possible muscle loss, if you lose weight too quickly (which is why balanced nutrition and movement matter) If youre pregnant or nursing, you should not take GLP-1s
How GLP-1 Medications Affect Neurotransmitters and Mental Health GLP-1 receptors exist throughout your brain, including regions controlling serotonin, dopamine, and cortisolneurotransmitters central to mood and anxiety
He began his medical career at Middlesex Hospital, UCL, where he was also a Medical Research Council clinical fellow